ACE and familial dilated cardiomyopathy: Currently, both drug-based treatments, such as angiotensin-converting enzyme (ACE) inhibitors and β-blockers, and non-drug treatments, such as left ventricular assist device (LVAD) therapy and heart transplantation, can significantly improve the prognosis of DCM patients7.